Trial intelligence / Profile preview

Evaluation of dexmedetomidine in reducing postoperative ocular pain

IRCT20200503047291N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in strabismus, Esotropia (ET), exotropia (XT) and 1 more, sponsored by Mashhad University of Medical Sciences. Started Sep 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

strabismusEsotropia (ET)exotropia (XT)post-operative ocular pain

Beyond the preview

Go deeper on IRCT20200503047291N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200503047291N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call